Correlation Between Arcus Biosciences and Valneva SE
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Valneva SE ADR, you can compare the effects of market volatilities on Arcus Biosciences and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Valneva SE.
Diversification Opportunities for Arcus Biosciences and Valneva SE
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Arcus and Valneva is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Valneva SE go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Valneva SE
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 0.64 times more return on investment than Valneva SE. However, Arcus Biosciences is 1.57 times less risky than Valneva SE. It trades about 0.14 of its potential returns per unit of risk. Valneva SE ADR is currently generating about 0.0 per unit of risk. If you would invest 1,456 in Arcus Biosciences on September 25, 2024 and sell it today you would earn a total of 139.00 from holding Arcus Biosciences or generate 9.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcus Biosciences vs. Valneva SE ADR
Performance |
| Timeline |
| Arcus Biosciences |
| Valneva SE ADR |
Arcus Biosciences and Valneva SE Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcus Biosciences and Valneva SE
The main advantage of trading using opposite Arcus Biosciences and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.| Arcus Biosciences vs. Fate Therapeutics | Arcus Biosciences vs. Caribou Biosciences | Arcus Biosciences vs. Karyopharm Therapeutics | Arcus Biosciences vs. X4 Pharmaceuticals |
| Valneva SE vs. Fate Therapeutics | Valneva SE vs. Caribou Biosciences | Valneva SE vs. Karyopharm Therapeutics | Valneva SE vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |